Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Igor Homola"'
Autor:
Erik Kudela, Karol Kajo, Erik Kozubik, Tomas Rokos, Terezia Pribulova, Jan Danko, Eva Kudelova, Igor Homola, Pavol Slavik, Barbora Macurova, Kamil Biringer
Publikováno v:
Case Reports in Obstetrics and Gynecology, Vol 2021 (2021)
Phyllodes tumors (PTs) are rare fibroepithelial neoplasms of the breast. They have a proliferating stromal component that can be graded as benign, borderline, and malignant. In addition, they are associated with an increased risk of local recurrence
Externí odkaz:
https://doaj.org/article/d8625fe3564e4b08a9a6acae0049af86
Autor:
Kamil Biringer, Pavol Slavik, Tomas Rokos, Jan Danko, Terezia Pribulova, Karol Kajo, Igor Homola, Barbora Macurova, Eva Kudelova, Erik Kozubik, Erik Kudela
Publikováno v:
Case Reports in Obstetrics and Gynecology
Case Reports in Obstetrics and Gynecology, Vol 2021 (2021)
Case Reports in Obstetrics and Gynecology, Vol 2021 (2021)
Phyllodes tumors (PTs) are rare fibroepithelial neoplasms of the breast. They have a proliferating stromal component that can be graded as benign, borderline, and malignant. In addition, they are associated with an increased risk of local recurrence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e800ac216ae63020d81f5fdac4ed1ec1
http://europepmc.org/articles/PMC8390174
http://europepmc.org/articles/PMC8390174
Autor:
Ivana Kasubova, Bibiana Malicherova, Tatiana Péčová, Zora Lasabova, Martina Bobrovska, E. Minarikova, Lukáš Plank, Igor Homola, Tatiana Burjanivova
Publikováno v:
Neoplasma. 66:33-38
Malignant melanoma is an oncological disease characterized by etiologic heterogeneity and it has increasing incidence and mortality in the Slovak Republic. While it is treated surgically in combination with chemotherapy, targeted therapy, and immunot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::464e14e4e26a52d53f5bc512b436e6f2
https://doi.org/10.4149/neo_2018_180115n31
https://doi.org/10.4149/neo_2018_180115n31
Autor:
Barbora Vanova, Zora Lasabova, Martina Bobrovska, Lukáš Plank, Marian Grendar, Bibiana Malicherova, Tatiana Péčová, R. Dusenka, E. Minarikova, Igor Homola, Tatiana Burjanivova
Publikováno v:
Genetic testing and molecular biomarkers. 23(4)
About 50% of melanomas have the BRAFV600E mutation. This mutation is an attractive therapeutic target. The aims of our study were to detect BRAFV600E mutations within circulating cell-free DNA in plasma ("liquid biopsy") by a droplet digital PCR (ddP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd4ce1eea4437c574ac51bdd31b194df
https://pubmed.ncbi.nlm.nih.gov/30676087
https://pubmed.ncbi.nlm.nih.gov/30676087
Autor:
Bibiana, Malicherova, Tatiana, Burjanivova, Marian, Grendar, Eva, Minarikova, Martina, Bobrovska, Barbora, Vanova, Karin, Jasek, Eva, Jezkova, Andrea, Kapinova, Martina, Antosova, Igor, Homola, Tatiana, Pecova, Zora, Lasabova, Lukas, Plank
Publikováno v:
American journal of translational research. 10(11)
Cutaneous melanoma has the worst prognosis of all skin cancers. Although emerging targeted therapies, such as B-Raf kinase inhibitor vemurafenib, improve prognosis they require an accurate and sensitive means of detecting the pathogenic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::65908c468e6564443eb1453c3e642ed2
https://pubmed.ncbi.nlm.nih.gov/30662627
https://pubmed.ncbi.nlm.nih.gov/30662627